EU-OPENSCREEN WEBINAR: DNA-encoded libraries to Identify Novel Chemical Matter

The speakers will present the DNA-encoded libraries (DEL) to Identify Novel Chemical Matter for Undruggable Targets - Webinar, a web-based theoretical overview for researchers and students considering DEL as part of their research.
• DEL technology is a game changing innovation in Drug Discovery to expand ligandability of targets.
• With DEL, synthesis and screening of millions (even billions) of novel and highly diverse drug-like compounds is more efficient than conventional methods to identify new ligands with instant SAR information and to assess target ligandability applicable across disease areas and target classes.
• It is now a well-established technology in the pharmaceutical industry used by GSK, Roche, Novartis, Pfizer, AZ, Merck, … and other companies in connection with the academic developments.
• A number of DEL-originated compounds are currently in clinical stages and may potentially impact drug development pipelines.